The National Institutes of Health (NIH) has awarded a two-year, $1.9m Phase II small business innovation research grant to Kensey Nash, to further evaluate the use of a bioadhesive surgical mesh for applications in tendon repair procedures.

The firm will develop and investigate the ability of its proprietary bioadhesive technology to improve sutured tendon repair, enhancing repair efficacy and patient outcomes.

Kensey Nash chief operating officer Doug Evans said the grant will allow the firm to explore new applications of adhesive technology along with other extracellular matrix, collagen, and polymer-based biomaterials to create new solutions for existing medical problems.

Kensey Nash manufactures cardiology, orthopaedic, sports medicine, spine, endovascular and general surgery products.